Clinical benefits of tight glycaemic control: effect on the kidney

Best Practice and Research: Clinical Anaesthesiology

Volumn 23, Issue 4, 2009, Pages 431-439

  Gunst, Jan ^a   Schetz, Miet ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

acute kidney injury; critical illness; glucose control; hyperglycaemia; insulin

Indexed keywords

C REACTIVE PROTEIN; CREATINE; GLUCOSE; INSULIN; LIPID;

ACUTE DISEASE; APOPTOSIS; BURN; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INFECTION PREVENTION; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LIPID METABOLISM; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT SAFETY; PRIORITY JOURNAL; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; KIDNEY FAILURE, ACUTE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 70749151297     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.08.003     Document Type: Review

References (86)

1. Bellomo R., Ronco C., Kellum J.A., et al., the ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 8 (2004) R204-R212
2. Lameire N., Van Biesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
3. Coca S.G., Yusuf B., Shlipak M.G., et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 53 (2009) 961-973
4. Ricci Z., Cruz D., and Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney International 73 (2008) 538-546
5. Lameire N., Van Biesen W., and Vanholder R. Acute kidney injury. Lancet 372 (2008) 1863-1865
6. Venkataraman R., and Kellum J.A. Prevention of acute renal failure. Chest 131 (2007) 300-308
7. Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. European Journal of Clinical Investigation 34 (2004) 785-796
8. Caramori M.L., and Mauer M. Diabetes and nephropathy. Current Opinion in Nephrology and Hypertension 12 (2003) 273-282
9. Schrijvers B.F., De Vriese A.S., and Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocrine Reviews 25 (2004) 971-1010
10. Singh D.K., Winocour P., and Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nature Clinical Practice. Nephrology 4 (2008) 216-226
11. Wang S., Mitu G.M., and Hirschberg R. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrology, Dialysis, Transplantation 23 (2008) 2167-2172
12. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., et al. Effects of intensive glucose lowering in type 2 diabetes. The New England Journal of Medicine 358 (2008) 2545-2559
13. ADVANCE Collaborative Group, Patel A., MacMahon S., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine 358 (2008) 2560-2572
14. Duckworth W., Abraira C., Moritz T., et al., VDAT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. The New England Journal of Medicine 360 (2009) 129-139
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 329 (1993) 977-986
16. The Diabetes Control and Complications (DCCT) Research Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney International 47 (1995) 1703-1720
17. U.K. Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk for complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
18. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA : The Journal of the American Medical Association 290 (2003) 2159-2167
19. Fioretto P., Bruseghin M., Berto I., et al. Renal protection in diabetes: role of glycaemic control. Journal of the American Society of Nephrology 17 (2006) S86-S89
20. Mizock B.A. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Practice & Research. Clinical Endocrinology & Metabolism 15 (2001) 533-551
21. Bagshaw S.M., Egi M., George C., Bellomo R., and the ANZICS Database Management Committee. Early blood glucose control and mortality in critically ill patients in Australia. Critical Care Medcine 37 (2009) 463-470
22. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
23. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings. Mayo Clinic 80 (2005) 862-866
24. Mangano C.M., Diamondstone L.S., Ramsay J.G., et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine 128 (1998) 194-203
25. Turcot D.B., Kiernan F.J., McKay R.G., et al. Acute hyperglycemia: implications for contrast-induced nephropathy during cardiac catheterization. Diabetes Care 27 (2004) 620-621
26. Cheung N.W., Napier B., Zaccaria C., et al. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 28 (2005) 2367-2371
27. Lin L.Y., Lin H.C., Lee P.C., et al. Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. The American Journal of the Medical Sciences 333 (2007) 261-265
28. Blasi-Ibanez A., Hirose R., Feiner J., et al. Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology 110 (2009) 333-341
29. Hirose R., Xu F., Dang K., et al. Transient hyperglycemia affects the extent of ischemia-reperfusion-induced renal injury in rats. Anesthesiology 108 (2008) 402-414
30. Moursi M., Rising C.L., Zelenock G.B., et al. Dextrose administration exacerbates acute renal ischemic damage in anesthetized dogs. Archives of Surgery 122 (1987) 790-804
31. Podrazik R.M., Natale J.E., Zelenock G.B., et al. Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat. The Journal of Surgical Research 46 (1989) 572-578
32. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. The New England Journal of Medicine 345 (2001) 1359-1367
33. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354 (2006) 449-461
34. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 31 Suppl. 1 (2008) S12-S54
35. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American association of clinical endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice 13 Suppl. 1 (2007) 1-68
36. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Critical Care Medcine 36 (2008) 296-327
37. Rydén L., Standl E., Bartnik M., et al., Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC), European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases; executive summary. European Heart Journal 28 (2007) 88-136
38. Devos P., Preiser J., and Melot C. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the glucontrol study (European Society of Intensive Care Medicine 20th Annual Congress abstract 0735). Intensive Care Medicine 33 Suppl. 2 (2007) S189
39. Brunkhorst F.M., Engel C., Bloos F., et al., German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 358 (2008) 125-139
40. Arabi Y.M., Dabbagh O.C., Tamim H.M., et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical Care Medcine 36 (2008) 3190-3197
41. De La Rosa G.d.C., Donado J.H., Restrepo A.H., et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care 12 (2008) R120
42. Bilotta F., Caramia R., Paoloni F.P., et al. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 110 (2009) 611-619
43. Finfer S., Chittock D.R., Su S.Y., et al., NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 360 (2009) 1283-1297
44. Inzucchi S.E., and Siegel M.D. Glucose control in the ICU - how tight is too tight?. The New England Journal of Medicine 360 (2009) 1346-1349
45. Preiser J.C. NICE-SUGAR: the end of a sweet dream?. Critical Care 13 (2009) 143
46. Comi R.J. Glucose control in the intensive care unit: a roller coaster ride or a swinging pendulum?. Annals of Internal Medicine 150 (2009) 809-811
47. Fahy B.G., Sheely A.M., and Coursin D.B. Glucose control in the intensive care unit. Critical Care Medcine 37 (2009) 1769-1776
48. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? The Journal of Clinical Endocrinology and Metabolism, in press (PMID: 19531590).
49. Schetz M., Vanhorebeek I., Wouters P.J., et al. Tight blood glucose control is renoprotective in critically ill patients. Journal of the American Society of Nephrology 19 (2008) 571-578
50. Van den Berghe G., Wilmer A., Milants I., et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55 (2006) 3151-3159
51. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings. Mayo Clinic 79 (2004) 992-1000 [Erratum in: Mayo Clinic Proceedings. Mayo Clinic 2005; 80: 1101]
52. Lecomte P., Van Vlem B., Coddens J., et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Critical Care 12 (2008) R154
53. Wiener R.S., Wiener D.C., and Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA : The Journal of the American Medical Association 300 (2008) 933-944
54. Scott M.G., Bruns D.E., Boyd J.C., and Sacks D.B. Tight glucose control in the intensive care unit: are glucose meters up to the task?. Clinical Chemistry 55 (2009) 18-20
55. Egi M., Bellomo R., Stachowski E., et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105 (2006) 244-252
56. Krinsley J.S. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Critical Care Medcine 36 (2008) 3008-3013
57. Egi M., Bellomo R., and Reade M.C. Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?. Critical Care 13 (2009) 302
58. Ellger B., Debaveye Y., Vanhorebeek I., et al. Survival benefits of intensive insulin therapy in critical illness. Diabetes 55 (2006) 1096-1105
59. Devarajan P. Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology 17 (2006) 1503-1520
60. Chatterjee P.K. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology 376 (2007) 1-43
61. Bonventre J. Ischemic acute renal failure: an inflammatory disease?. Kidney International 66 (2004) 480-485
62. Kaushal G.P., Basnakian A.G., and Shah S.V. Apoptotic pathways in ischemic acute renal failure. Kidney International 66 (2004) 500-506
63. Wan L., Bagshaw S.M., Langenberg C., et al. Pathophysiology of septic acute kidney injury: what do we really know?. Critical Care Medcine 36 Suppl. (2008) S198-S203
64. Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Critical Care Medcine 35 Suppl. (2007) S441-S448
65. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
66. Forbes M., Coughlan M.T., and Cooper M.E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57 (2008) 1446-1454
67. Ha H., Hwang I.A., park J.H., et al. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Research and Clinical Practice 82 Suppl. 1 (2008) S42-S45
68. Langouche L., Vander Perre S., Wouters P., and Van den Berghe G. Expression of glucose transporters in critical illness. (abstract). Critical Care 10 Suppl. 1 (2006) P252
69. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. The Journal of Clinical Investigation 9 (2004) 1187-1195
70. Choi S.W., Benzie I.F.F., Ma S.W., et al. Acute hyperglycemia and oxidative stress: direct cause and effect?. Free Radical Biology & Medicine 44 (2008) 1217-1231
71. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA : The Journal of the American Medical Association 295 (2006) 1681-1687
72. Langouche L., Vanhorebeek I., Vlasselaers D., et al. Intensive insulin therapy protects the endothelium of critically ill patients. The Journal of Clinical Investigation 115 (2005) 2277-2286
73. Vanhorebeek I., De Vos R., Mesotten D., et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
74. Vanhorebeek I., Gunst J., Ellger B., et al. Hyperglycemic damage to renal tissue in an animal model of prolonged critical illness. Kindey International 76 (2009) 512-520
75. Vanhorebeek I., Ellger B., De Vos R., et al. Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Critical Care Medcine 37 (2009) 1355-1364
76. Dandona P., Chaudhuri A., Ghanim H., et al. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Seminars in Thoracic and Cardiovascular Surgery 18 (2006) 293-301
77. Weekers F., Giulietti A.P., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
78. Schalkwijk C.G., and Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clinical Science (London, England : 1979) 109 (2005) 143-159
79. Molitoris B.A., and Sutton T.A. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney International 66 (2004) 496-499
80. Allen D.A., Harwood S., Varagunam M., et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. The FASEB Journal 17 (2003) 908-910
81. Ortiz A., Ziyadeh F.N., and Neilson E.G. Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. Journal of Investigative Medicine 45 (1997) 50-56
82. Samikkannu T., Thomas J.J., Bhat J., et al. Acute effect of high glucose on long term cell growth: a role for transient glucose increase in proximal tubule cell injury. American Journal of Physiology. Renal Physiology 291 (2006) F162-F175
83. Meier M., Nitschke M., Hocke C., et al. Insulin inhibits caspase-3 activity in human renal tubular epithelial cells via the PI3-Kinase/Akt pathway. Cellular Physiology and Biochemistry 21 (2008) 279-286
84. Melin J., Hellberg O., Larsson E., et al. Protective effect of insulin on ischemic renal injury in diabetes mellitus. Kidney International 61 (2002) 383-392
85. Mesotten D., Swinnen J.V., Vanderhoydonc F., et al. Contribution of circulating lipids to the improved outcome of critical illness by glycaemic control with intensive insulin therapy. The Journal of Clinical Endocrinology and Metabolism 89 (2004) 219-226
86. Thiemermann C., Patel N.S.A., Kvale E.O., et al. High Density Lipoprotein (HDL) reduces renal ischemia/reperfusion injury. Journal of the American Society of Nephrology 14 (2003) 1833-1843